Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
20 participants
INTERVENTIONAL
2025-04-01
2026-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercises on Children and Adolescents With Type 1 Diabetes Mellitus (T1DM)
NCT06680557
Exercise in Type 1 Diabetes Mellitus
NCT02075567
Exercise in Adolescents With Type 1 Diabetes
NCT04418869
Comparison of the Use of Energy Substrates and Hormonal Regulation of Blood Sugar During Exercise of Increasing Intensity Between Children With Type 1 Diabetes and Non-diabetic Control Children.
NCT03139864
An Evaluation of Internet-based Carbohydrate Counting Education for Adolescents With Type 1 Diabetes
NCT02462785
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Former and current KADET athletes invited via a Facebook group. Previous participants in study projects who have expressed interest in being contacted for future studies.
Protocol:
Participants provide written consent for data collection and use.
Each participant completes two training sessions under controlled conditions, including:
Same training time Standardized pre-training meal timing and insulin corrections Similar intensity and environmental factors If pre-training hypoglycemia occurs, training is rescheduled or corrected with glucose tablets, which are documented.
Study Conditions:
Session 1: Participant eats a banana 20 minutes before training. Session 2: No pre-training food intake.
Tandem Control IQ users (insulin pump) take a microbolus (0.05 IE) before banana intake.
Recorded Data by participant:
Training start and end times Sensor glucose (SG) at start and end of training Training type and intensity (Borg scale, heart rate monitoring) Last insulin dose (meal and correction) Last meal details (content and timing) Banana documentation (photo, weight with peel, ripeness level)
CGM data are also assessed.
Endpoints:
Differences in GCG glucose level Time to hypoglycemia and number of hypoglycemia events (SG \<3.9 mmol/L) on banana vs. non-banana days.
Percentage of Time in Range during training. Additional data is reported as available.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No banana
No banana consumed prior exercise
No banana
No banana is consumed pre-exercise
banana
Banana consumed 20 minutes prior exercise
Banana
A banana is consumed pre-exercise in order to prevent hypoglycemia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Banana
A banana is consumed pre-exercise in order to prevent hypoglycemia
No banana
No banana is consumed pre-exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* neuropathy
15 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-10-72-9-25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.